Open AccessTARGET THERAPY OF BRONCHIAL ASTHMA WITH LEUKOTRIENE RECEPTOR AGONISTS
Author(s) -
Natalia Nenasheva
Publication year - 2013
Publication title -
rossijskij allergologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2686-682X
pISSN - 1810-8830
DOI - 10.36691/rja625
Subject(s) - montelukast , asthma , leukotriene , medicine , receptor , leukotriene receptor , immunology , phenotype , inflammation , leukotriene e4 , leukotriene d4 , biology , gene , biochemistry
This article describes the features of asthma phenotypes such as asthma in smokers and asthma and obesity. The role of cysteinyl leukotrienes is discussed in the formation of inflammation in these phenotypes of asthma. The leukotriene receptor antagonists, including montelukast are effective in therapy of this category of patients.